Aclaris's drug to treat common skin growth gets FDA nod Ruby Khatun Khatun18 Dec 2017 4:30 AM GMTAclaris Therapeutics Inc's drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug...